Meige’s syndrome treatment

• Subthalamic Nucleus Oscillatory Characteristics in Meige, Cervical Dystonia and Generalized Dystonia
• CT-guided extracranial radiofrequency of multiple groups of cranial nerves for the treatment of compound Meige's syndrome
• Clinical outcomes and prognostic factors in patients with primary Meige syndrome undergoing subthalamic nucleus deep brain stimulation: a retrospective study of 65 cases
• Experience of the application of botulinum toxin type A as a treatment of facial hyperkinetic disorders in a Mexican ophthalmological center
• Putaminal-cortical circuits predict response of bilateral deep brain stimulation of the subthalamic nucleus in the primary Meige syndrome after 5 years
• Prognostic factors for long-term outcomes of bilateral pallidal deep brain stimulation in the treatment of Meige syndrome
• Efficacy comparison and outcome predictors of GPi- and STN-targeted deep brain stimulation for Meige syndrome: a systematic review of individual patient data
• Progress in MGJWS: A 74-Year Review of Marcus Gunn Jaw-Winking Syndrome

It is a disabling disease, especially when refractory to treatment with botulinum toxin.

The treatment of Meige syndrome is directed toward the specific symptoms that are apparent in each individual. Treatment consists of drug therapy and botulinum A toxin (Botox) injections used separately or in combination. Approximately one-third of affected individuals are treated with oral medications (drug therapy) ¹⁾

Deep brain stimulation for Meige’s syndrome.